DRI Healthcare Trust (TSX:DHT.UN)
Canada · Delayed Price · Currency is CAD 17.42
-0.18 (-1.02%)
Aug 28, 2026, 4:00 PM EST
DRI Healthcare Trust Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 957 | 885 | 666 | 703 | 305 | 271 | |
Market Cap Growth | 21.50% | 32.94% | -5.35% | 130.55% | 12.69% | - |
Enterprise Value | 1,515 | 1,457 | 1,008 | 988 | 572 | 288 |
Last Close Price | 17.42 | 15.78 | 11.15 | 11.33 | 6.25 | 4.93 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 5.82 | 20.58 | 9.92 |
Forward PE | 4.95 | 4.96 | 3.99 | 5.93 | 2.77 | 2.72 |
PS Ratio | 3.36 | 3.37 | 2.47 | 3.20 | 2.42 | 2.62 |
PB Ratio | 1.55 | 1.47 | 0.88 | 0.95 | 0.61 | 0.56 |
P/TBV Ratio | - | - | - | - | - | 2.51 |
P/FCF Ratio | 5.60 | 5.92 | 2.98 | 6.97 | 2.93 | 2.33 |
P/OCF Ratio | 5.55 | 5.87 | 2.98 | 6.97 | 2.93 | 2.33 |
PEG Ratio | - | 0.18 | 0.18 | 0.18 | 0.23 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.31 | 5.54 | 3.75 | 4.50 | 4.54 | 2.78 |
EV/EBITDA Ratio | 6.20 | 6.84 | 4.67 | 7.02 | 5.41 | 3.43 |
EV/EBIT Ratio | 15.47 | 19.87 | 14.91 | 38.06 | 22.44 | 9.30 |
EV/FCF Ratio | 8.86 | 9.75 | 4.51 | 9.80 | 5.50 | 2.47 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.03 | 1.11 | 0.82 | 0.43 | 0.66 | 0.12 |
Debt / EBITDA Ratio | 2.60 | 3.12 | 2.88 | 2.25 | 3.14 | 0.66 |
Debt / FCF Ratio | 3.72 | 4.45 | 2.78 | 3.14 | 3.19 | 0.48 |
Net Debt / Equity Ratio | 0.90 | 1.00 | 0.74 | 0.32 | 0.56 | -0.05 |
Net Debt / EBITDA Ratio | 2.28 | 2.82 | 2.61 | 1.66 | 2.67 | -0.27 |
Net Debt / FCF Ratio | 3.26 | 4.03 | 2.52 | 2.32 | 2.71 | -0.19 |
Asset Turnover | 0.21 | 0.20 | 0.21 | 0.23 | 0.17 | 0.37 |
Quick Ratio | 0.68 | 1.18 | 1.21 | 1.55 | 1.28 | 4.84 |
Current Ratio | 0.69 | 1.19 | 1.21 | 1.56 | 1.29 | 4.87 |
Return on Equity (ROE) | -9.39% | -10.45% | -0.62% | 19.65% | 2.92% | 11.38% |
Return on Assets (ROA) | 4.43% | 3.47% | 3.23% | 1.68% | 2.20% | 7.00% |
Return on Capital Employed (ROCE) | 8.40% | 6.20% | 5.20% | 2.60% | 3.20% | 5.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -6.53% | -7.82% | -0.73% | 17.18% | 4.86% | 10.08% |
FCF Yield | 17.86% | 16.88% | 33.59% | 14.34% | 34.10% | 42.94% |
Dividend Yield | 3.41% | 3.48% | 4.39% | 3.50% | 6.49% | 4.28% |
Payout Ratio | - | - | - | 35.72% | 184.65% | 17.06% |
Buyback Yield / Dilution | 1.14% | 1.07% | -26.26% | -15.63% | -11.36% | - |
Total Shareholder Return | 4.56% | 4.55% | -21.87% | -12.13% | -4.87% | 4.28% |